Gefitinib Tablets Ip

Gefitinib Tablets Ip

Get Latest Price

In Stock

Product Specifications

Dosage	250mg
Form	Tablets
Packaging	Bottle, box
Material	Pharmaceutical grade
Expiry	Specified on packaging
Storage	Room temperature
Route	Oral
Features	Cancer treatment, Targeted therapy, 250mg dosage, Non-small cell lung cancer, Improved survival
Main Domestic Market	All India

Product Overview

Key Features

Company Details

Business Type

Exporter, Manufacturer, Distributor, Supplier, Trading Company

Employee Count

25

Establishment

2014

Working Days

Monday To Saturday

GST NO

27AKFPJ6383E1Z2

Related Products

Explore Related Categories

Cancer Herbal Medicine

Anti Cancer Injection

More Products From This Seller

Xtandi

Xtandi

Ceritinib Hard Gelatin Capsules 150 mg

Ceritinib Hard Gelatin Capsules 150 mg

Lenalidomide Capsules 5mg - C13H13N3O3 Compound, Protein Binding 30% | Immunomodulation, Angiogenesis Inhibition, Cancer and Anemia Treatment

Lenalidomide Capsules 5mg - C13H13N3O3 Compound, Protein Binding 30% | Immunomodulation, Angiogenesis Inhibition, Cancer and Anemia Treatment

Melphalan Tablets IP - 2mg C13H18Cl2N2O2, Oral Blister Pack | Cancer Treatment, High Bioavailability, Fast Acting

Melphalan Tablets IP - 2mg C13H18Cl2N2O2, Oral Blister Pack | Cancer Treatment, High Bioavailability, Fast Acting

Ledihep Tablets - Ledipasvir Sofosbuvir Combination, 28 Round Tablets | Hepatitis C Treatment, Convenient Dosage, Improved Prognosis

Ledihep Tablets - Ledipasvir Sofosbuvir Combination, 28 Round Tablets | Hepatitis C Treatment, Convenient Dosage, Improved Prognosis

Decitabine Lyophilized for Injection - Decitabine 50 mg/Vial, Lyophilized Powder | MDS Treatment, Intravenous, Refrigerated Storage

Decitabine Lyophilized for Injection - Decitabine 50 mg/Vial, Lyophilized Powder | MDS Treatment, Intravenous, Refrigerated Storage

Sorafenib Tablets - 200mg, C21H16ClF3N4O3 Molecular Formula | Kinase Inhibitor, Tumor Suppression, High Protein Binding

Sorafenib Tablets - 200mg, C21H16ClF3N4O3 Molecular Formula | Kinase Inhibitor, Tumor Suppression, High Protein Binding

Tafero EM Tablets - 200mg/25mg Emtricitabine Tenofovir, HIV and Hepatitis B Treatment, Oral Tablet, Blister Pack

Tafero EM Tablets - 200mg/25mg Emtricitabine Tenofovir, HIV and Hepatitis B Treatment, Oral Tablet, Blister Pack

Instgra Dolutegravir Tablet - White, 50mg, Round, 30 Tablets | HIV Treatment, Viral Suppression, Once-Daily Dosage

Instgra Dolutegravir Tablet - White, 50mg, Round, 30 Tablets | HIV Treatment, Viral Suppression, Once-Daily Dosage

Zoledronic Acid Injection IP - 4mg Vial, C5H10N2O7P2 | Bisphosphonate, Treats Osteoporosis, Paget's Disease, Hypercalcemia, IV Administration

Zoledronic Acid Injection IP - 4mg Vial, C5H10N2O7P2 | Bisphosphonate, Treats Osteoporosis, Paget's Disease, Hypercalcemia, IV Administration

Seller Details

Bull Pharmachem

GST - 27AKFPJ6383E1Z2

Mumbai, Maharashtra

MD & CEO

Mr. Parag Jain

Address

64C Dhan Sadan Co-operative Housing Society, 2nd Floor, Old Hanuman Lane 1st Cross Lane , Kalbadevi, Mumbai, Maharashtra, 400002, India

anti cancer medicine in Mumbai

Report incorrect details

Recommended Products

Xovoltib - 40mg Tablets for Non-Small Cell Lung Cancer Treatment | Targeted Kinase Inhibitor to Slow Cancer Cell Growth

Xovoltib - 40mg Tablets for Non-Small Cell Lung Cancer Treatment | Targeted Kinase Inhibitor to Slow Cancer Cell Growth

Vivimed Laboratories Limited

Entecavir Tablets Ip 0.5 Mg - Bottle, 30 Tablets | Anti-Viral, Chronic Hepatitis B Treatment, Adult Use

Entecavir Tablets Ip 0.5 Mg - Bottle, 30 Tablets | Anti-Viral, Chronic Hepatitis B Treatment, Adult Use

Adcock Ingram

Emfib 250mg Tablet - Gefitinib, 10 Tablets/Strip, Oral | Cancer Treatment, Long Shelf Life

Emfib 250mg Tablet - Gefitinib, 10 Tablets/Strip, Oral | Cancer Treatment, Long Shelf Life

Million Health Pharmaceuticals

Gefitero Tablet - 250mg, Long Shelf Life, Accurate Composition, Properly Packed

Gefitero Tablet - 250mg, Long Shelf Life, Accurate Composition, Properly Packed

Million Health Pharmaceuticals

Gefitinib Tablets - 250 MG | Anti-Cancer, Suitable For All, As per Doctor Instruction

Gefitinib Tablets - 250 MG | Anti-Cancer, Suitable For All, As per Doctor Instruction

K Diam Exim

Megestrol Acetate Tablets - 40 mg | Effective Anti-Cancer Treatment for Breast and Endometrial Cancer, Suitable for All

Megestrol Acetate Tablets - 40 mg | Effective Anti-Cancer Treatment for Breast and Endometrial Cancer, Suitable for All

K Diam Exim

Compare With Similar Products

Product Name

Gefitinib Tablets IP

Suniheet 50(Sinitinib Malate Capsules

Dinogest Tablet

Buyer Feedback

3

3

5

Main Domestic Market

All India

All India

Price Or Price Range

180.00 - 210.00 USD ($) (Approx.)

6 USD ($) (Approx.)

Minimum Order Quantity

10 Bottle/Bottles

2 Tablet

Enzyme Types

Other

Other

Temperature Needed For Fermentation

ROOM TEMPRATURE Celsius (oC)

ROOM TEMP Fahrenheit (oF)

Physical Color/Texture

Other

Other

Fermentation Smell

Normal Smell

Normal Smell

Shelf Life

2 Years

3 Years

Payment Terms

Letter of Credit (L/C), Telegraphic Transfer (T/T), Others

Letter of Credit (L/C), Paypal, Western Union, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Others, Cash in Advance (CID), Cash Advance (CA)

Supply Ability

2 Per Week

150 Per Day

Delivery Time

2 Week

2 Days

Sample Available

Yes

Yes

Sample Policy

Within a certain price range free samples are available

Sample costs shipping and taxes has to be paid by the buyer

Packaging Details

10 CAPSULES IN 1 BOTTLE

10X10

Main Export Market(s)

Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Central America, Asia, Africa

North America, South America, Western Europe, Middle East, Africa, Central America, Asia

Certifications

COAMSDS

WHO AND GMP

Sold By

Bull Pharmachem
Mumbai, Maharashtra

G R Medex
Nagpur, Maharashtra

Golden Era Pharma
Mumbai, Maharashtra

Japan|China|Taiwan|Thailand|Malaysia|Indonesia| UAE|Saudi Arabia|USA|Iran|Other Countries

Connect with us

Grievances Privacy Policy Terms & Conditions

© 1999-2026 Infocom Network Private Limited. All rights reserved.